At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder
In Brief
A Phase 4 clinical trial evaluating Fluoxetine, Dialectical Behavior Therapy, and 1 other intervention for Borderline Personality Disorder. Completed, enrolled 91 participants across 1 site.
Detailed Summary
This study will determine whether dialectical behavior therapy and fluoxetine are more effective combined or alone in treating people with borderline personality disorder.
Study Details
Timeline
Interventions
Fluoxetine is administered in standard dosing 20, 40, 60, 80 mg increased monthly if tolerated
Dialectical Behavior Therapy is a form of CBT originally developed to treat suicidal and self injuring individuals with borderline personality disorder. Treatment consists of 2 sessions/week: individual psychotherapy and skills training group.
Supportive therapy is a manualized form of psychotherapy designed to enhance individual's strengths and coping mechanisms while reducing distress.